From: Prevalence of SARS-CoV-2 infection in neonates born to mothers or relatives with COVID-19
Parameters | Positive | Negative | Total | P value | |
---|---|---|---|---|---|
No | 6 (6.1%) | 92 (93.9%) | 98 (100.0%) | – | |
Age of neonates/days at the time of sampling | 2.8 ± 2.0 (1–5 days) | 4.8 ± 7.0 (1–28 days) | 4.7 ± 6.8 (1–28 days) | 0.274 Mann-Whitney U Test | |
Age groups of neonates (Days) | 1–10 | 6 (100.0%) | 83 (90.2%) | 89 (90.8%) | 0.633 Chi-Square Test |
11–28 | 0 (0.0%) | 9 (9.8%) | 9 (9.8%) | ||
Neonatal maturity | Mature | 5 (83.3%) | 76 (82.6%) | 81 (82.7%) | 0.722 Chi-Square Test |
Immature | 1 (16.7%) | 16 (17.4%) | 17 (17.3%) | ||
Epidemiological characteristics of neonates | |||||
 None | 2 (33.3%) | 51 (55.4%) | 53 (54.1%) | 0.409 Fisher’s exact Test | |
 Fever | 4 (66.7%) | 11 (12.0%) | 15 (15.3%) | 0.005a Fisher’s exact Test | |
 General weakness | 0 (0.0%) | 4 (4.3%) | 4 (4.1%) | 1.000 Fisher’s exact Test | |
 Dyspnea | 2 (33.3%) | 23 (25.0%) | 25 (25.5%) | 0.643 Fisher’s exact Test | |
 Confusion | 0 (0.0%) | 2 (2.2%) | 2 (2.0%) | 1.000 Fisher’s exact Test | |
 Dry cough | 1 (16.7%) | 3 (3.3%) | 4 (4.1%) | 0.226 Fisher’s exact Test | |
 Tachycardia | 1 (16.7%) | 0 (0.0%) | 1 (1.0%) | 0.061 Fisher’s exact Test | |
 Cardiovascular disease | 0 (0.0%) | 1 (1.1%) | 1 (1.0%)) | 1.000 Fisher’s exact Test |